JASMYNE PETTY: Open Payments
NPI 1376241661 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 72 payments from 19 companies in 2025. Trend: 2023 $504 · 2024 $1,013 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $148 |
| ABBVIE INC. | 13 | $143 |
| Novo Nordisk Inc | 15 | $142 |
| AstraZeneca Pharmaceuticals LP | 8 | $139 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| PFIZER INC. | 4 | $66 |
| Organon LLC | 4 | $48 |
| Dynavax Technologies Corporation | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 3 | $31 |
Products named: AUSTEDO XR, VRAYLAR, AIRSUPRA, Wegovy, Jornay PM, NURTEC ODT, Ozempic, NEXPLANON.
Industry payments across OK — which companies pay providers there.
